Format

Send to

Choose Destination
J Altern Complement Med. 2002 Apr;8(2):135-42.

Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense).

Author information

1
Department of Obstetrics and Gynaecology, St George Hospital/UNSW, Kogarah, New South Wales, Australia.

Abstract

OBJECTIVES:

To study the pharmacokinetics of isoflavones from red clover (Trifolium pratense) after long-term administration as a once-daily dietary supplementary.

DESIGN:

Fourteen (14) subjects who had been consuming a low-isoflavone diet for 2 weeks were given an oral dose of two isoflavone tablets (approximately 80 mg of total isoflavones) daily for 2 weeks and appeared for a study day at 9:00 AM after an overnight fast on the day that they were to receive the last dose. Plasma samples were collected for a 48-hour period after the last dose. Plasma isoflavones were assayed by high-performance liquid chromatography (HPLC).

RESULTS:

Trough plasma levels were significantly higher for daidzein and genistein after long-term dosing than levels taken prior to the commencement of the study and plasma levels of isoflavones after long-term dosing were in the range previously reported in populations that consume an isoflavone-rich diet. The plasma half-lives observed after long-term administration were, in most cases, consistent with once-daily administration.

CONCLUSIONS:

Isoflavones have pharmacokinetic characteristics that suggest that once-daily administration is adequate when they are administered long-term as dietary supplements.

PMID:
12006121
DOI:
10.1089/107555302317371424
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center